News & InformationAbout AuxiliumTestim®Product PipelineNews And InformationFor InvestorsFor InvestorsCareers
For Investors
Receive E-mail AlertsE-mail Alerts
|
RSS Feeds RSS
Webcast ImageWebcast
Auxilium Pharmaceuticals, Inc. at Bank of America Merrill Lynch Health Care Conference (Replay)
May 15, 2013 at 3:00 p.m. PT
Webcast ImageWebcast
Auxilium Pharmaceuticals, Inc. at UBS Global Healthcare Conference  (Live)
May 21, 2013 at 3:00 p.m. ET
Keyword Search
 

Below please find a listing of the most recent Auxilium press releases.

DateTitle 
May 15, 2013Auxilium Pharmaceuticals, Inc. To Present At The UBS Global Health Care ConferencePrinter Friendly Version
May 10, 2013Auxilium Pharmaceuticals, Inc. To Present At The Bank Of America Merrill Lynch 2013 Health Care ConferencePrinter Friendly Version
Apr 29, 2013Auxilium Pharmaceuticals, Inc, Announces First Quarter 2013 Financial ResultsPrinter Friendly Version
Apr 29, 2013Auxilium Pharmaceuticals Completes Acquisition Of Actient Holdings LLC To Create A Leading Urology Franchise With A Diversified Product Portfolio And Strong Growth ProfilePrinter Friendly Version
Apr 25, 2013Auxilium Pharmaceuticals to Announce First Quarter 2013 Results and Conduct Conference Call on Monday, April 29, 2013Printer Friendly Version
Mar 25, 2013Auxilium Pharmaceuticals, Inc. Announces Positive Top-line Data from XIAFLEX® (CCH) Frozen Shoulder Syndrome Phase IIa StudyPrinter Friendly Version
Mar 4, 2013Auxilium Pharmaceuticals, Inc. to Present at the Cowen and Company 33rd Annual Healthcare ConferencePrinter Friendly Version
Feb 26, 2013Auxilium Pharmaceuticals, Inc. Announces Fourth Quarter and Full Year 2012 Financial Results and Guidance for 2013Printer Friendly Version
Feb 12, 2013Auxilium Pharmaceuticals to Announce Fourth Quarter and Full Year 2012 Results and Conduct Conference Call on Tuesday, February 26, 2013Printer Friendly Version
Feb 12, 2013Auxilium Pharmaceuticals, Inc. to Present at the Leerink Swann Global Healthcare ConferencePrinter Friendly Version
Feb 1, 2013Auxilium Pharmaceuticals, Inc. Announces IMPRESS Trials of XIALFEX® in Peyronie's Disease Were Published Online in The Journal of UrologyPrinter Friendly Version
Jan 30, 2013Auxilium Pharmaceuticals, Inc. Announces Issuance of $350.0 Million of 1.50% Convertible Senior Notes Due 2018Printer Friendly Version
Jan 28, 2013Auxilium Pharmaceuticals, Inc. and Xstelos Holdings, Inc. File Lawsuit Against Upsher-Smith Laboratories, Inc. for Infringement of Testim® PatentsPrinter Friendly Version
Jan 25, 2013Auxilium Pharmaceuticals, Inc. Announces Pricing of $325.0 Million of 1.50% Convertible Senior Notes Due 2018Printer Friendly Version
Jan 23, 2013Auxilium Pharmaceuticals, Inc. Announces Offering of Convertible Senior Notes Due 2018Printer Friendly Version
Jan 7, 2013Auxilium Pharmaceuticals, Inc. Announces Expansion of Its Exclusive License for XIAFLEX® (CCH) to Include the Potential Treatment of Cellulite as an Additional IndicationPrinter Friendly Version
Jan 3, 2013Auxilium Pharmaceuticals, Inc. and Xstelos Holdings, Inc. Receive 505(b)(2) Paragraph IV Certification Notice from Upsher-Smith Laboratories, Inc. for Testim®Printer Friendly Version
Jan 3, 2013Auxilium Pharmaceuticals to Present at the J.P. Morgan 2013 Healthcare ConferencePrinter Friendly Version
Dec 27, 2012U.S. Food and Drug Administration Accepts XIAFLEX® Supplemental Biologics License Application Filing for the Treatment of Peyronie's DiseasePrinter Friendly Version
Dec 13, 2012Auxilium Pharmaceuticals Announces Encouraging Top-line 30-Day Data from XIAFLEX® (CCH) Phase Ib Study in CellulitePrinter Friendly Version
Dec 7, 2012Auxilium Pharmaceuticals, Inc. to Present At The Oppenheimer 23rd Annual Growth ConferencePrinter Friendly Version
Nov 7, 2012Auxilium and Pfizer Will Conclude Agreement on XIAPEX® EU CollaborationPrinter Friendly Version
Nov 7, 2012Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2012 Financial ResultsPrinter Friendly Version
Nov 7, 2012Auxilium Pharmaceuticals, Inc. Submits Supplemental Biologics License Application to the FDA for XIAFLEX® for the Treatment of Peyronie's DiseasePrinter Friendly Version
Nov 1, 2012Auxilium Pharmaceuticals to Announce Third Quarter 2012 Results and Conduct Conference Call on Wednesday, November 7, 2012Printer Friendly Version
Sep 5, 2012Auxilium Pharmaceuticals, Inc. Announces 30 Month XIAFLEX® Safety UpdatePrinter Friendly Version
Aug 27, 2012Auxilium Pharmaceuticals Announces Additional Phase III XIAFLEX® Data To Be Presented at SMSNA MeetingPrinter Friendly Version
Aug 8, 2012Auxilium Pharmaceuticals, Inc. to Present at the Canaccord Genuity 32nd Annual Growth ConferencePrinter Friendly Version
Jul 31, 2012Auxilium Pharmaceuticals, Inc. Announces Second Quarter 2012 Financial ResultsPrinter Friendly Version
Jul 30, 2012Auxilium Pharmaceuticals, Inc. Announces Positive Top-line Data from XIAFLEX® Phase IIIb Dupuytren's Contracture Multicord StudyPrinter Friendly Version
Jul 24, 2012Auxilium Pharmaceuticals to Announce Second Quarter 2012 Results and Conduct Conference Call on Tuesday, July 31, 2012Printer Friendly Version
Jul 9, 2012Auxilium and Actelion Announce Approval of XIAFLEX® In CanadaPrinter Friendly Version
Jul 6, 2012Auxilium Pharmaceuticals, Inc. to Present At The JMP Securities 2012 Healthcare ConferencePrinter Friendly Version
Jun 4, 2012Auxilium Pharmaceuticals, Inc. Announces Positive Top-line Results from Both Phase III Trials of XIAFLEX® for the Potential Treatment of Peyronie's DiseasePrinter Friendly Version
May 30, 2012Auxilium Pharmaceuticals, Inc. to Present at the Goldman Sachs Global Healthcare Conference 2012Printer Friendly Version
May 30, 2012Auxilium Pharmaceuticals, Inc. to Present at the Jefferies 2012 Global Healthcare ConferencePrinter Friendly Version
May 24, 2012Auxilium Pharmaceuticals, Inc. and FCB I LLC File Lawsuit Against Watson for Infringement of Testim® PatentsPrinter Friendly Version
May 21, 2012Auxilium Pharmaceuticals, Inc. Raises Revenue Guidance And Reduces Net Loss Guidance For 2012Printer Friendly Version
May 21, 2012Auxilium Pharmaceuticals, Inc. and GlaxoSmithKline LLC Enter Into a Co-Promotion Agreement for Testim® in the U.S.Printer Friendly Version
May 17, 2012Auxilium Pharmaceuticals, Inc. and FCB I LLC Announce the Issuance of Composition of Matter Patent Covering TestimPrinter Friendly Version
May 11, 2012Auxilium Pharmaceuticals, Inc. to Present At The BofAML 2012 Health Care ConferencePrinter Friendly Version
May 10, 2012Auxilium Pharmaceuticals, Inc. Announces First Quarter 2012 Financial ResultsPrinter Friendly Version
May 9, 2012Auxilium Pharmaceuticals, Inc. Announces XIAFLEX® Peyronie's Phase IIb Study Published In The Journal Of UrologyPrinter Friendly Version
May 3, 2012Auxilium Pharmaceuticals to Announce First Quarter 2012 Results and Conduct Conference Call on Thursday, May 10, 2012Printer Friendly Version
Apr 24, 2012Auxilium Pharmaceuticals to Present at the Deutsche Bank 37th Annual Healthcare ConferencePrinter Friendly Version
Apr 16, 2012Auxilium Pharmaceuticals, Inc. and FCB I LLC Receive Paragraph IV Certification Notice from Watson Laboratories, Inc. for Testim®Printer Friendly Version
Mar 26, 2012Auxilium Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)Printer Friendly Version
Mar 8, 2012Auxilium Pharmaceuticals to Present at the 2012 Barclays Capital Global Healthcare ConferencePrinter Friendly Version
Feb 29, 2012Auxilium Partners With the National Organization for Rare Disorders to Observe Rare Disease DayPrinter Friendly Version
Feb 27, 2012Auxilium Pharmaceuticals to Present at the 2012 Cowen Healthcare ConferencePrinter Friendly Version
Feb 23, 2012Auxilium Pharmaceuticals, Inc. Announces Fourth Quarter and Full Year 2011 Financial Results and Guidance for 2012Printer Friendly Version
Feb 23, 2012Auxilium Pharmaceuticals, Inc. and Actelion Pharmaceuticals Ltd. Enter a Collaboration Agreement for XIAFLEX® in Canada, Australia, Brazil and MexicoPrinter Friendly Version
Feb 15, 2012Auxilium Pharmaceuticals to Present at the 2012 RBC Global Healthcare ConferencePrinter Friendly Version
Feb 15, 2012Auxilium Pharmaceuticals to Present at the Citi 2012 Global Healthcare ConferencePrinter Friendly Version
Feb 9, 2012Auxilium Pharmaceuticals to Announce Fourth Quarter 2011 Results and Conduct Conference Call on Thursday, February 23, 2012Printer Friendly Version
Feb 6, 2012Auxilium Announces Appointments to Enhance Leadership TeamPrinter Friendly Version
Feb 1, 2012Auxilium Pharmaceuticals to Present at the Leerink Swann 2012 Global Healthcare ConferencePrinter Friendly Version
Jan 26, 2012Auxilium Pharmaceuticals, Inc. Announces First Patients Dosed in XIAFLEX® Phase Ib Cellulite StudyPrinter Friendly Version
Jan 4, 2012Auxilium Pharmaceuticals to Present at the 30th Annual J.P. Morgan Healthcare ConferencePrinter Friendly Version
Dec 8, 2011Auxilium Pharmaceuticals, Inc. Appoints Adrian Adams Chief Executive Officer and PresidentPrinter Friendly Version
Dec 1, 2011Auxilium Pharmaceuticals, Inc. Announces First Patient Dosed in XIAFLEX® Study for Frozen Shoulder SyndromePrinter Friendly Version
Dec 1, 2011Auxilium Pharmaceuticals, Inc. Announces First Patient Dosed in XIAFLEX(R) Study for Frozen Shoulder SyndromePrinter Friendly Version
Nov 28, 2011Auxilium Pharmaceuticals to Present at the Oppenheimer 22nd Annual Healthcare ConferencePrinter Friendly Version
Nov 3, 2011TRiUS Data Suggests That Testim® Significantly Improved Sexual Function in Hypogonadal MenPrinter Friendly Version
Nov 2, 2011Auxilium Pharmaceuticals, Inc. Announces Publication of U.S. CPT® Codes and Related Reimbursement Rates for XIAFLEX®Printer Friendly Version
Oct 31, 2011Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2011 Financial Results and Recent Operational HighlightsPrinter Friendly Version
Oct 17, 2011Auxilium Pharmaceuticals to Announce Third Quarter 2011 Results and Conduct Conference Call on Monday, October 31, 2011Printer Friendly Version
Oct 13, 2011Auxilium Pharmaceuticals Announces Hypogonadism Awareness Ad Campaign Wins Medical Marketing & Media AwardPrinter Friendly Version
Oct 3, 2011Auxilium Pharmaceuticals, Inc. Announces First Patient Enrolled in XIAFLEX® Phase IIIb Dupuytren's Contracture Multicord StudyPrinter Friendly Version
Sep 13, 2011Auxilium Pharmaceuticals to Present at the 2011 UBS Global Life Sciences ConferencePrinter Friendly Version
Sep 8, 2011Auxilium Pharmaceuticals Announces Additional Data from Three-Year XIAFLEX® Recurrence Study in Dupuytren's Contracture in E-poster at ASSH MeetingPrinter Friendly Version
Sep 8, 2011Auxilium Pharmaceuticals Announces Positive Data from Commercial Patient Chart Review in E-posters at ASSH MeetingPrinter Friendly Version
Sep 7, 2011Auxilium Pharmaceuticals, Inc. Announces Positive Top-Line Results from XIAFLEX® Multi-Cord StudyPrinter Friendly Version
Sep 6, 2011Auxilium Pharmaceuticals, Inc. Announces 17 Month XIAFLEX® Safety UpdatePrinter Friendly Version
Aug 31, 2011Auxilium Pharmaceuticals, Inc. and BioSpecifics Technologies Corp. Announce Plans to Develop Additional Indications using XIAFLEX®Printer Friendly Version
Aug 31, 2011Auxilium Pharmaceuticals to Present at the Morgan Stanley 2011 Healthcare ConferencePrinter Friendly Version
Aug 31, 2011Auxilium Pharmaceuticals Announces Investor Event to Occur at 2011 ASSH Meeting on September 9, 2011Printer Friendly Version
Aug 24, 2011Auxilium Pharmaceuticals to Present at the Stifel Nicolaus 2011 Healthcare ConferencePrinter Friendly Version
Aug 8, 2011Auxilium Pharmaceuticals, Inc. Announces Promotion of Dr. James P. Tursi to Chief Medical OfficerPrinter Friendly Version
Aug 1, 2011Auxilium Pharmaceuticals, Inc. Announces Second Quarter 2011 Financial Results and Recent Operational HighlightsPrinter Friendly Version
Jul 18, 2011Auxilium Pharmaceuticals to Announce Second Quarter 2011 Results and Conduct Conference Call on Monday, August 1, 2011Printer Friendly Version
Jun 30, 2011Auxilium Pharmaceuticals Announces Results from Three Year CORDLESS Extension Study in Dupuytren's ContracturePrinter Friendly Version
May 25, 2011Auxilium Pharmaceuticals to Present at the Jefferies 2011 Health Care ConferencePrinter Friendly Version
May 20, 2011Auxilium Pharmaceuticals, Inc. Updates Launch Progress of XIAPEX® in EUPrinter Friendly Version
May 9, 2011Auxilium Pharmaceuticals, Inc. Announces First Quarter 2011 Financial Results and Operational HighlightsPrinter Friendly Version
May 4, 2011Auxilium Pharmaceuticals to Present at the Bank of America Merrill Lynch 2011 Health Care ConferencePrinter Friendly Version
Apr 25, 2011Auxilium Pharmaceuticals to Announce First Quarter 2011 Results and Conduct Conference Call on Monday, May 9, 2011Printer Friendly Version
Apr 20, 2011Auxilium Pharmaceuticals to Present at the Deutsche Bank 36th Annual Health Care ConferencePrinter Friendly Version
Apr 11, 2011Auxilium Pharmaceuticals, Inc. Announces Launch of XIAPEX(R) in EU by PfizerPrinter Friendly Version
Mar 22, 2011Auxilium Pharmaceuticals, Inc. and Asahi Kasei Pharma Corporation Enter Agreement to Develop, Commercialize and Supply XIAFLEX(R) In JapanPrinter Friendly Version
Mar 9, 2011Auxilium Pharmaceuticals, Inc. Completes Enrollment of XIAFLEX(R) Phase III Double-Blind Studies for Peyronie's DiseasePrinter Friendly Version
Mar 2, 2011Auxilium Pharmaceuticals to Present at the Cowen and Company 31st Annual Health Care ConferencePrinter Friendly Version
Feb 28, 2011XIAPEX® (Collagenase Clostridium Histolyticum) Authorized In The European Union (EU) For Dupuytren’s ContracturePrinter Friendly Version
Feb 25, 2011Auxilium Pharmaceuticals to Present at the 2011 Citi Annual Global Healthcare ConferencePrinter Friendly Version
Feb 10, 2011Auxilium Pharmaceuticals, Inc. Announces Fourth Quarter and Full Year 2010 Financial Results, Guidance for 2011Printer Friendly Version
Feb 3, 2011Auxilium Pharmaceuticals to Announce Fourth Quarter and Full Year 2010 Results and Conduct Conference Call on Thursday, February 10, 2011Printer Friendly Version
Jan 10, 2011Auxilium Pharmaceuticals Reports Preliminary Fourth Quarter 2010 Net Revenue and Announces 2011 XIAFLEX Revenue GuidancePrinter Friendly Version
Dec 21, 2010Auxilium Pharmaceuticals to Present at the 2011 29th Annual J.P. Morgan Healthcare ConferencePrinter Friendly Version
Dec 20, 2010Peter Brandt Joins Board of Auxilium Pharmaceuticals, Inc.Printer Friendly Version
Dec 16, 2010XIAPEX® (Collagenase Clostridium Histolyticum) Receives Positive CHMP OpinionPrinter Friendly Version
Dec 6, 2010XIAFLEX(R) Effective in Nonsurgically Treating MP and PIP Joints with Dupuytren's Contractures in Second Pivotal StudyPrinter Friendly Version
Nov 4, 2010Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2010 Financial Results and Operational HighlightsPrinter Friendly Version
Oct 21, 2010Auxilium Pharmaceuticals to Announce Third Quarter 2010 Results and Conduct Conference Call on Thursday, November 4, 2010Printer Friendly Version
Oct 12, 2010Auxilium Pharmaceuticals, Inc. Announces Issuance of Patent for Clostridial CollagenasePrinter Friendly Version
Oct 11, 2010Auxilium Pharmaceuticals, Inc. Announces Initiation of XIAFLEX(R) Phase III Studies for Peyronie's DiseasePrinter Friendly Version
Sep 8, 2010Auxilium Pharmaceuticals to Present at the UBS Global Life Sciences ConferencePrinter Friendly Version
Sep 1, 2010Auxilium Pharmaceuticals to Present at the Morgan Stanley Global Healthcare Conference and the Stifel Nicolaus Healthcare ConferencePrinter Friendly Version
Aug 11, 2010Auxilium Pharmaceuticals to Present at the Bank of America Merrill Lynch Specialty Pharmaceuticals ConferencePrinter Friendly Version
Aug 5, 2010Auxilium Pharmaceuticals, Inc. Announces Second Quarter 2010 Financial Results and Operational HighlightsPrinter Friendly Version
Jul 22, 2010Auxilium Pharmaceuticals to Announce Second Quarter 2010 Results and Conduct Conference Call on Thursday, August 5, 2010Printer Friendly Version
Jul 12, 2010Auxilium Pharmaceuticals Announces 2Q 2010 XIAFLEX(R) Net Revenues of $3.1 MillionPrinter Friendly Version
Jul 9, 2010Auxilium Pharmaceuticals to Host Conference Call to Discuss XIAFLEX(R) Launch and Development Update on July 12, 2010Printer Friendly Version
Jun 8, 2010Auxilium Pharmaceuticals Announces Two Year Recurrence Rate of 19.3% for Joints Treated With XIAFLEX(R)Printer Friendly Version
Jun 1, 2010Auxilium Pharmaceuticals to Present at the Goldman Sachs Global Healthcare ConferencePrinter Friendly Version
May 25, 2010Auxilium Pharmaceuticals to Present at the Jefferies 2010 Global Life Sciences ConferencePrinter Friendly Version
May 12, 2010Auxilium Pharmaceuticals to Present at the 2010 Citi Annual Global Healthcare ConferencePrinter Friendly Version
May 6, 2010Auxilium Pharmaceuticals to Present at Bank of America Merrill Lynch Health Care ConferencePrinter Friendly Version
May 3, 2010Auxilium Pharmaceuticals, Inc. Announces First Quarter 2010 Financial Results and Operational HighlightsPrinter Friendly Version
Apr 19, 2010Auxilium Pharmaceuticals to Present at the Deutsche Bank Securities 35th Annual Health Care ConferencePrinter Friendly Version
Apr 19, 2010Auxilium Pharmaceuticals to Announce First Quarter 2010 Results and Conduct Conference Call on Monday, May 3, 2010Printer Friendly Version
Mar 29, 2010Auxilium Announces Promotion of Benjamin Del Tito Jr., Ph.D. to Executive Vice President, Regulatory Affairs and Project ManagementPrinter Friendly Version
Mar 11, 2010Auxilium Announces Managed Distribution Network Partners Supporting XIAFLEX(TM)Printer Friendly Version
Mar 8, 2010Auxilium Announces Availability of XIAFLEX(TM) for the Treatment of Dupuytren's ContracturePrinter Friendly Version
Mar 4, 2010Auxilium Pharmaceuticals to Present at the Cowen and Co. 30th Annual Health Care ConferencePrinter Friendly Version
Feb 17, 2010Auxilium Pharmaceuticals, Inc. Announces Fourth Quarter and Full Year 2009 Financial Results, Guidance for 2010 and Selling Price for XIAFLEXPrinter Friendly Version
Feb 4, 2010Auxilium Pharmaceuticals to Announce Fourth Quarter and Full Year 2009 Results and Conduct Conference Call on Wednesday, February 17, 2010Printer Friendly Version
Feb 2, 2010Auxilium Announces U.S. Food and Drug Administration Approval for XIAFLEX(TM) for the Treatment of Dupuytren's ContracturePrinter Friendly Version
Jan 21, 2010Pfizer and Auxilium Announce Commencement of European Regulatory Review of XIAFLEXTM for the Treatment of Dupuytren's ContracturePrinter Friendly Version
Dec 31, 2009Auxilium Pharmaceuticals to Present at the 28th Annual J.P. Morgan Healthcare ConferencePrinter Friendly Version
Dec 16, 2009Auxilium Announces Top Line Phase IIb XIAFLEX(TM) Peyronie's ResultsPrinter Friendly Version
Nov 11, 2009Auxilium Pharmaceuticals to Present at the Lazard Capital Markets 6th Annual Healthcare ConferencePrinter Friendly Version
Nov 10, 2009Auxilium Pharmaceuticals to Present at the Credit Suisse 18th Annual Global Healthcare ConferencePrinter Friendly Version
Nov 2, 2009Auxilium Pharmaceuticals to Present at the Oppenheimer 20th Annual Healthcare ConferencePrinter Friendly Version
Oct 28, 2009Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2009 Financial Results and Operational HighlightsPrinter Friendly Version
Oct 14, 2009Auxilium Pharmaceuticals to Announce Third Quarter 2009 Results and Conduct Conference Call on Wednesday, October 28, 2009Printer Friendly Version
Oct 1, 2009Auxilium Pharmaceuticals Completes Sale of 3.45 Million Shares of Common Stock Resulting in $115.7 Million in Net ProceedsPrinter Friendly Version
Sep 25, 2009Auxilium Pharmaceuticals, Inc. Announces Pricing of a Public Offering of Common StockPrinter Friendly Version
Sep 16, 2009U.S. Food and Drug Administration's Arthritis Advisory Committee Votes Unanimously 12-0 to Recommend Approval of XIAFLEX(TM) for Dupuytren's ContracturePrinter Friendly Version
Sep 8, 2009Auxilium Pharmaceuticals to Present at the UBS Global Life Sciences ConferencePrinter Friendly Version
Sep 2, 2009XIAFLEX(TM) CORD I Study Published in New England Journal of MedicinePrinter Friendly Version
Aug 27, 2009Auxilium Pharmaceuticals to Present at the Thomas Weisel Partners 2009 Healthcare ConferencePrinter Friendly Version
Aug 6, 2009Auxilium Pharmaceuticals, Inc. Announces Second Quarter 2009 Financial Results and Operational HighlightsPrinter Friendly Version
Aug 5, 2009Auxilium Pharmaceuticals, Inc. Secures $30 Million Revolving Credit Line With Silicon Valley BankPrinter Friendly Version
Jul 31, 2009U.S. Food and Drug Administration's Arthritis Advisory Committee Confirms Date to Review XIAFLEX(TM) for the Treatment of Dupuytren's ContracturePrinter Friendly Version
Jul 23, 2009Auxilium Pharmaceuticals to Announce Second Quarter 2009 Results and Conduct Conference Call on Thursday, August 6, 2009Printer Friendly Version
Jul 21, 2009Data Presented at the 5th International AIDS Society Conference Suggests Low Testosterone Frequently Goes Undetected in HIV-Positive MenPrinter Friendly Version
Jun 18, 2009U.S. Food and Drug Administration's Arthritis Advisory Committee Sets Tentative Date to Review XIAFLEX(TM) for the Treatment of Dupuytren's ContracturePrinter Friendly Version
Jun 5, 2009Auxilium Pharmaceuticals to Present at the Jefferies 3rd Annual Healthcare ConferencePrinter Friendly Version
May 6, 2009Auxilium Pharmaceuticals, Inc. Announces First Quarter 2009 Financial Results and Operational HighlightsPrinter Friendly Version
May 5, 2009Auxilium Pharmaceuticals to Present at the Deutsche Bank 34th Annual Health Care ConferencePrinter Friendly Version
Apr 30, 2009Auxilium Pharmaceuticals to Present at the Bank of America and Merrill Lynch 2009 Health Care ConferencePrinter Friendly Version
Apr 28, 2009XIAFLEX(TM) for the Treatment of Dupuytren's Contracture Receives Priority Review From the U.S. Food and Drug AdministrationPrinter Friendly Version
Apr 15, 2009Auxilium Pharmaceuticals to Announce First Quarter 2009 Results and Conduct Conference Call on Wednesday, May 6, 2009Printer Friendly Version
Mar 20, 2009William T. McKee Joins Board of Auxilium Pharmaceuticals, Inc.Printer Friendly Version
Mar 18, 2009Auxilium Pharmaceuticals to Present at Citi's 4th Annual Biotech DayPrinter Friendly Version
Mar 10, 2009Auxilium Pharmaceuticals to Present at the Cowen and Company 29th Annual Health Care ConferencePrinter Friendly Version
Mar 2, 2009Auxilium Submits Biologics License Application for XIAFLEX(TM) for the Treatment of Dupuytren's Contracture to the U.S. Food and Drug AdministrationPrinter Friendly Version
Feb 18, 2009Auxilium Pharmaceuticals, Inc. Announces Fourth Quarter and Full Year 2008 Financial Results, as Well as Guidance for 2009Printer Friendly Version
Feb 4, 2009Auxilium Pharmaceuticals to Announce Fourth Quarter and Full Year 2008 Results and Conduct Conference Call on Wednesday, February 18, 2009Printer Friendly Version
Feb 2, 2009Auxilium Pharmaceuticals, Inc. Completes Enrollment in Phase IIb Clinical Trial of XIAFLEX(TM) in Peyronie's DiseasePrinter Friendly Version
Dec 17, 2008Auxilium Pharmaceuticals, Inc. and Pfizer Enter Agreement to Develop and Commercialize XIAFLEX(TM) in EuropePrinter Friendly Version
Dec 4, 2008Auxilium Pharmaceuticals, Inc. and CPEX Pharmaceuticals, Inc. File Lawsuit Against Upsher-Smith Laboratories, Inc. for Infringement of Testim(R) PatentPrinter Friendly Version
Dec 1, 2008Auxilium Pharmaceuticals, Inc. Announces Distribution and License Agreement for Testim(R) in Europe With Ferring PharmaceuticalsPrinter Friendly Version
Nov 18, 2008Auxilium Pharmaceuticals to Present at the Piper Jaffray 20th Annual Healthcare ConferencePrinter Friendly Version
Nov 7, 2008Auxilium Pharmaceuticals to Present at the Lazard Capital Markets 5th Annual Healthcare ConferencePrinter Friendly Version
Oct 29, 2008Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2008 Financial Results and Operational HighlightsPrinter Friendly Version
Oct 24, 2008Auxilium Pharmaceuticals, Inc. and CPEX Pharmaceuticals, Inc. Receive Paragraph IV Certification Notice From Upsher-Smith Laboratories for Testim(R)Printer Friendly Version
Oct 21, 2008Auxilium Pharmaceuticals to Present at the 19th Annual Oppenheimer Healthcare ConferencePrinter Friendly Version
Oct 15, 2008Auxilium Pharmaceuticals to Announce Third Quarter 2008 Results and Conduct Conference Call on Wednesday, October 29, 2008Printer Friendly Version
Sep 18, 2008Auxilium Pharmaceuticals to Present at the 2008 UBS Global Life Sciences ConferencePrinter Friendly Version
Sep 17, 2008Auxilium Pharmaceuticals, Inc. Announces Initiation of XIAFLEX(TM) Phase IIb Study for Peyronie's DiseasePrinter Friendly Version
Sep 2, 2008Auxilium Pharmaceuticals to Present at the Morgan Stanley Global Healthcare Unplugged ConferencePrinter Friendly Version
Aug 26, 2008Auxilium Pharmaceuticals to Present at the Thomas Weisel Partners Healthcare ConferencePrinter Friendly Version
Jul 31, 2008Auxilium Pharmaceuticals, Inc. Announces Second Quarter 2008 Financial Results and Operational HighlightsPrinter Friendly Version
Jul 17, 2008Auxilium Pharmaceuticals to Announce Second Quarter 2008 Results and Conduct Conference Call on Thursday, July 31, 2008Printer Friendly Version
Jun 18, 2008Auxilium Pharmaceuticals to Present at the Jefferies 2nd Annual Healthcare ConferencePrinter Friendly Version
Jun 3, 2008/ CORRECTION - Auxilium Pharmaceuticals, Inc. Announces XIAFLEX(TM) Meets Primary Endpoint With Statistical Significance (p < 0.001) in CORD I Pivotal Phase III Study for Dupuytren's ContracturePrinter Friendly Version
Jun 3, 2008Auxilium Pharmaceuticals, Inc. Announces XIAFLEX(TM) Meets Primary Endpoint With Statistical Significance (p < 0.001) in CORD I Pivotal Phase III Study for Dupuytren's ContracturePrinter Friendly Version
May 21, 2008Auxilium Pharmaceuticals to Present at the FBR Capital Markets 12th Annual Spring Investor ConferencePrinter Friendly Version
May 14, 2008Auxilium Pharmaceuticals to Present at the Citigroup 2008 Global Healthcare ConferencePrinter Friendly Version
May 7, 2008Auxilium Pharmaceuticals to Present At the Bank of America 2008 Healthcare ConferencePrinter Friendly Version
Apr 30, 2008Auxilium Pharmaceuticals, Inc. Announces First Quarter 2008 Financial Results and Operational HighlightsPrinter Friendly Version
Apr 29, 2008Auxilium Pharmaceuticals to Present at the Deutsche Bank 33rd Annual Health Care ConferencePrinter Friendly Version
Apr 24, 2008Auxilium Pharmaceuticals to Present at the Morgan Stanley Global Healthcare Unplugged ConferencePrinter Friendly Version
Apr 10, 2008Auxilium Pharmaceuticals to Announce First Quarter 2008 Results and Conduct Conference Call on Wednesday, April 30, 2008 Printer Friendly Version
Mar 10, 2008Auxilium Pharmaceuticals to Present at the Cowen and Company 28th Annual Health Care ConferencePrinter Friendly Version
Feb 14, 2008Auxilium Pharmaceuticals, Inc. Announces Fourth Quarter and Full Year 2007 Financial Results, as Well as Guidance for 2008Printer Friendly Version
Jan 29, 2008Auxilium Pharmaceuticals to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device ConferencePrinter Friendly Version
Jan 25, 2008Auxilium Pharmaceuticals to Present at the 2008 Wachovia Healthcare ConferencePrinter Friendly Version
Jan 24, 2008Auxilium Pharmaceuticals to Announce Fourth Quarter and Full Year 2007 Results and Conduct Conference Call on Thursday, February 14, 2008Printer Friendly Version
Jan 22, 2008Auxilium Pharmaceuticals, Inc. and Bentley Pharmaceuticals, Inc. Announce Issuance of Patent Covering Testim(R)Printer Friendly Version
Dec 17, 2007Auxilium Pharmaceuticals, Inc. Completes Enrollment in Two Phase III Clinical Trials of XIAFLEX(TM) for Dupuytren's ContracturePrinter Friendly Version
Dec 10, 2007Auxilium Pharmaceuticals Named 'Life Sciences Company of the Year' by Eastern Technology CouncilPrinter Friendly Version
Nov 15, 2007Auxilium Pharmaceuticals to Present At the 19th Annual Piper Jaffray Healthcare ConferencePrinter Friendly Version
Oct 31, 2007Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2007 Financial Results and Operational HighlightsPrinter Friendly Version
Oct 15, 2007Auxilium Pharmaceuticals to Announce Third Quarter 2007 Results and Conduct Conference Call on Wednesday, October 31, 2007Printer Friendly Version
Oct 10, 2007Auxilium Pharmaceuticals to Webcast Analyst and Institutional Investor Meeting on October 17, 2007Printer Friendly Version
Sep 28, 2007Auxilium Pharmaceuticals to Present at ThinkEquity's 2007 ThinkClinic Healthcare ConferencePrinter Friendly Version
Sep 20, 2007Auxilium Pharmaceuticals to Present at the 2007 UBS Global Life Sciences ConferencePrinter Friendly Version
Sep 10, 2007Auxilium Pharmaceuticals, Inc. Announces First Patients Dosed in XIAFLEX(TM) U.S. Pivotal Phase III StudyPrinter Friendly Version
Aug 27, 2007Auxilium Pharmaceuticals to Present at the 2007 Thomas Weisel Partners Healthcare ConferencePrinter Friendly Version
Aug 16, 2007Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)Printer Friendly Version
Jul 31, 2007Auxilium Pharmaceuticals, Inc. Announces Second Quarter 2007 Financial Results and Operational HighlightsPrinter Friendly Version
Jul 24, 2007The Journal of Hand Surgery Publishes Initial Phase III Data on XIAFLEX(TM) (formerly known as AA4500), Auxilium's Investigational Treatment for Patients with Dupuytren's ContracturePrinter Friendly Version
Jul 24, 2007Dr. Dennis Langer Joins Board of Auxilium Pharmaceuticals, Inc.Printer Friendly Version
Jul 11, 2007Auxilium Pharmaceuticals to Announce Second Quarter 2007 Results and Conduct Conference Call on Tuesday, July 31, 2007Printer Friendly Version
Jun 28, 2007Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities ConferencePrinter Friendly Version
Jun 19, 2007Dr. Renato Fuchs Joins Board of Auxilium Pharmaceuticals, Inc.Printer Friendly Version
Jun 13, 2007Auxilium Pharmaceuticals Completes Sale of 3.672 million Shares of Common Stock Resulting in $49.9 million in Net ProceedsPrinter Friendly Version
Jun 8, 2007Auxilium Pharmaceuticals Announces Sale of Common StockPrinter Friendly Version
Jun 7, 2007Auxilium Pharmaceuticals to Present at the 2007 Needham Biotechnology & Medical Technology ConferencePrinter Friendly Version
May 22, 2007Auxilium Announces New Data That Show Total Testosterone Blood Levels Increase Significantly Following Switch from AndroGel(R) to Testim(R)Printer Friendly Version
May 16, 2007Auxilium Pharmaceuticals to Present at Investor Conferences in May 2007Printer Friendly Version
May 2, 2007Auxilium Pharmaceuticals to Present at the 2007 UBS Global Generic and Specialty Pharmaceuticals ConferencePrinter Friendly Version
May 1, 2007Auxilium Pharmaceuticals, Inc. Announces First Quarter 2007 Financial Results and Operational HighlightsPrinter Friendly Version
Apr 24, 2007Auxilium Pharmaceuticals to Present at the 32nd Annual Deutsche Bank Health Care ConferencePrinter Friendly Version
Apr 10, 2007Auxilium Pharmaceuticals to Announce First Quarter 2007 Results and Conduct Conference Call on Tuesday, May 1, 2007Printer Friendly Version
Apr 2, 2007Auxilium Pharmaceuticals to Present at the CIBC World Markets Annual Biotechnology and Specialty Pharmaceuticals ConferencePrinter Friendly Version
Mar 8, 2007Auxilium Pharmaceuticals to Present at the Cowen and Company 27th Annual Healthcare Conference on March 15thPrinter Friendly Version
Feb 20, 2007Auxilium Announces Results from Phase III Trial that Show AA4500 Successful in Treating Dupuytren's ContracturePrinter Friendly Version
Feb 15, 2007Auxilium Pharmaceuticals, Inc. Announces Fourth Quarter and Full Year 2006 Financial Results, as well as Guidance for 2007Printer Friendly Version
Feb 13, 2007Auxilium Pharmaceuticals to Present at the Roth Capital Partners Conference on February 20thPrinter Friendly Version
Feb 5, 2007Auxilium Pharmaceuticals to Announce Fourth Quarter and Full Year 2006 Results and Conduct Conference Call on Thursday, February 15, 2007Printer Friendly Version
Feb 5, 2007Auxilium Pharmaceuticals to Present at Merrill Lynch Investor Conference on February 8Printer Friendly Version
Dec 12, 2006Auxilium Pharmaceuticals, Inc. Announces Distribution Agreement With Paladin Labs for Testim(R) in CanadaPrinter Friendly Version
Dec 6, 2006Auxilium Pharmaceuticals, Inc. Temporarily Suspends Dosing in Phase III Trials for AA4500 in Dupuytren's ContracturePrinter Friendly Version
Nov 29, 2006Auxilium Pharmaceuticals Amends Agreement with Cobra Biologics Ltd.Printer Friendly Version
Nov 20, 2006Auxilium Pharmaceuticals, Inc. Initiates Phase III Trials for AA4500 in Dupuytren's ContracturePrinter Friendly Version
Nov 20, 2006Auxilium Pharmaceuticals to Present at the 18th Annual Piper Jaffray Healthcare Conference on November 30Printer Friendly Version
Nov 14, 2006Auxilium Pharmaceuticals Selected for Inclusion in the NASDAQ Biotechnology IndexPrinter Friendly Version
Nov 3, 2006Auxilium Pharmaceuticals to Present at the CIBC World Markets 17th Annual Healthcare Conference on November 8Printer Friendly Version
Oct 31, 2006Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2006 Financial ResultsPrinter Friendly Version
Oct 27, 2006Auxilium Pharmaceuticals to Present at the Susquehanna International Group Investor Conference on November 1Printer Friendly Version
Oct 25, 2006AA4500 Showed Marked Improvement in Patients With Peyronie's Disease in Phase II StudiesPrinter Friendly Version
Oct 18, 2006Auxilium Pharmaceuticals Announces R&D Portfolio ChangePrinter Friendly Version
Oct 17, 2006Auxilium Pharmaceuticals to Announce Third Quarter 2006 Results and Conduct Conference Call on Tuesday, October 31, 2006Printer Friendly Version
Sep 20, 2006Auxilium Pharmaceuticals Completes Sale of 5.5 Million Shares of Common Stock Resulting in $43.3 Million in Net ProceedsPrinter Friendly Version
Sep 20, 2006Auxilium Pharmaceuticals to Present at the UBS Global Life Sciences Conference on September 27Printer Friendly Version
Sep 15, 2006Auxilium Pharmaceuticals Announces Sale of Common StockPrinter Friendly Version
Sep 13, 2006Auxilium Pharmaceuticals to Present at Merriman Curhan Ford's Investor Conference on September 18Printer Friendly Version
Sep 5, 2006Auxilium Pharmaceuticals Announces New Strategic InitiativesPrinter Friendly Version
Aug 31, 2006Auxilium Pharmaceuticals to Present at Thomas Weisel Partner's Healthcare Investor ConferencePrinter Friendly Version
Aug 2, 2006Auxilium Pharmaceuticals, Inc. Announces Second Quarter 2006 Financial ResultsPrinter Friendly Version
Jul 17, 2006Auxilium Pharmaceuticals Signs Agreement With Cobra Biologics Ltd. for Manufacture of AA4500Printer Friendly Version
Jul 13, 2006Auxilium Pharmaceuticals to Announce Second Quarter 2006 Results and Conduct Conference Call on Wednesday, August 2, 2006Printer Friendly Version
Jul 6, 2006Auxilium Pharmaceuticals to Present at C.E. Unterberg Towbin, LLC ('CEUT') Emerging Growth Opportunities Investor ConferencePrinter Friendly Version
Jun 29, 2006Auxilium Pharmaceuticals Announces Start of U.S. Phase III Pivotal Trial of Testosterone Transmucosal Film (AA2600) for HypogonadismPrinter Friendly Version
Jun 26, 2006Auxilium Files Registration Statement for Previously Issued SecuritiesPrinter Friendly Version
Jun 26, 2006Auxilium Appoints Armando Anido as Chief Executive Officer and PresidentPrinter Friendly Version
Jun 24, 2006Researchers Find Evidence of Potential Markers for Cardiovascular Disease in Hypogonadal Type 2 Diabetes PatientsPrinter Friendly Version
Jun 21, 2006Auxilium Pharmaceuticals Announces Top-Line Results from a Pivotal Efficacy Study of AA4500 in Dupuytren's Disease and Revises 2006 Financial GuidancePrinter Friendly Version
Jun 15, 2006Auxilium Pharmaceuticals Announces Top-Line Results From Phase IV Trial of Testim(R) in Patients With Type II DiabetesPrinter Friendly Version
Jun 12, 2006Data Presented at American Diabetes Association Annual Meeting Suggest Testosterone Levels Correlate with Insulin Resistance and Insulin Sensitivity in Type 2 Diabetes PatientsPrinter Friendly Version
May 23, 2006Auxilium Pharmaceuticals Receives Approval to Sell Testim(R) in CanadaPrinter Friendly Version
May 9, 2006Auxilium Pharmaceuticals, Inc. Announces First Quarter 2006 Financial ResultsPrinter Friendly Version
Apr 20, 2006Auxilium Pharmaceuticals to Present at UBS Specialty Pharmaceuticals Investor ConferencePrinter Friendly Version
Apr 20, 2006Auxilium Pharmaceuticals to Announce First Quarter 2006 Results and Conduct Conference Call on Tuesday, May 9, 2006Printer Friendly Version
Mar 30, 2006Auxilium Pharmaceuticals to Present at CIBC Investor ConferencePrinter Friendly Version
Mar 7, 2006Auxilium Pharmaceuticals, Inc. Announces Fourth Quarter and Full Year 2005 Financial Results, as well as Guidance for 2006Printer Friendly Version
Feb 16, 2006Auxilium Pharmaceuticals to Announce Fourth Quarter and Full Year 2005 Results and Conduct Conference Call on Tuesday, March 7, 2006Printer Friendly Version
Feb 14, 2006Auxilium Pharmaceuticals to Present at Roth Capital Partners Investor ConferencePrinter Friendly Version
Feb 7, 2006Auxilium Pharmaceuticals to Present on Panel at the 2006 BIO CEO & Investor ConferencePrinter Friendly Version
Jan 25, 2006Auxilium Pharmaceuticals to Present at Brean Murray, Carret Investor ConferencePrinter Friendly Version